UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 6
June-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIRFY06015


Registration ID:
513000

Page Number

107-116

Share This Article


Jetir RMS

Title

QUANTIFICATION DETERMINATION OF NEPAFENAC IN OPHTHALMIC SUSPENSION USING HIGH PERFORMNACE THIN LAYER CHROMATOGHRAPHY

Abstract

Nepafenac is a pro drug with low inherent cyclooxygenase-inhibiting activity. The active non steriodial anti-inflammatory drug compound of nepafenac is called amfenac (2-amino-3-benzoylbenzeneacetic acid) which is an non steriodial anti-inflammatory drug with an arylacetic acid structure exhibiting potent antipyretic and analgesic properties. Nepafenac is designated chemically as 2-amino-3-benzoylbenzeneacetamide with an empirical formula of C15H14N2O2 and molecular weight of 254.28 g/mol. Nepafenac is a member of the new class of non steriodial anti-inflammatory pro drugs for ophthalmic use, providing a novel drug delivery mechanism. The analgesic and anti-inflammatory effect of nepafenac is the result of its fast penetration through the cornea in addition to conversion to amfenac.Present paper describes a high performance thin layer chromatographic for determination of nepafenac from Ophthalmic suspension. Separation was performed on aluminium-backed silica gel 60 F254 HPTLC plates with Toluene : Acetone : Glacial acetic acid (6 : 4 : 0.25) as mobile phase. After development, plates were observed under UV and detection and quantification were performed by densitometry at λ = 254 nm. Detection and quantitation limits for nepafenac is 0.8 µg/mL and 2 µg/mL. Nepafenac response was linear over the range 10 µg/mL to 30 µg/mL. The developed method was validated to determine its accuracy, precision and stability by carrying out linearity and stability experiments. The method developed is simple, fast, accurate and precise and hence can applied for routine quality control analysis from Pharmaceutical preparations / Ophthalmic suspensions.

Key Words

Nepafenac, HPTLC, Silica Gel, Densitometery, Ophthalmic suspension

Cite This Article

"QUANTIFICATION DETERMINATION OF NEPAFENAC IN OPHTHALMIC SUSPENSION USING HIGH PERFORMNACE THIN LAYER CHROMATOGHRAPHY", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 6, page no.107-116, June-2023, Available :http://www.jetir.org/papers/JETIRFY06015.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"QUANTIFICATION DETERMINATION OF NEPAFENAC IN OPHTHALMIC SUSPENSION USING HIGH PERFORMNACE THIN LAYER CHROMATOGHRAPHY", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 6, page no. pp107-116, June-2023, Available at : http://www.jetir.org/papers/JETIRFY06015.pdf

Publication Details

Published Paper ID: JETIRFY06015
Registration ID: 513000
Published In: Volume 10 | Issue 6 | Year June-2023
DOI (Digital Object Identifier):
Page No: 107-116
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000110

Print This Page

Current Call For Paper

Jetir RMS